The participants attending the workshop were informed that a total of 3, 684 MDR-TB cases were treated in 2022, while the target of 7, 960 per year has been set for 2026, with the treatment success rate of over 80pc from 2024 onwards. The drug resistance is developed through TB bacteria that are resistant to at least two most potent TB drugs. The participants agreed to increase the proportion of notified TB cases with known HIV status from 52pc in 2021 to over 95pc by 2026 and to treat 100pc of
综合
黎明报-最新
2024-01-25 00:00:00.0